Premium
Pharmacokinetics of ceftriaxone administered by the intravenous, intramuscular or subcutaneous routes to dogs
Author(s) -
REBUELTO M.,
ALBARELLOS G.,
AMBROS L.,
KREIL V.,
MONTOYA L.,
BONAFINE R.,
OTERO P.,
HALLU R.
Publication year - 2002
Publication title -
journal of veterinary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 60
eISSN - 1365-2885
pISSN - 0140-7783
DOI - 10.1046/j.1365-2885.2002.00389.x
Subject(s) - ceftriaxone , pharmacokinetics , volume of distribution , crossover study , bioavailability , medicine , cmax , intramuscular injection , absorption (acoustics) , anesthesia , chemistry , antibiotics , pharmacology , placebo , biochemistry , physics , alternative medicine , pathology , acoustics
The purpose of this study was to investigate the pharmacokinetics of ceftriaxone after single intravenous (i.v.), intramuscular (i.m.) and subcutaneous (s.c.) doses in healthy dogs. Six mongrel dogs received ceftriaxone (50 mg/kg) by each route in a three‐way crossover design. Blood samples were collected in predetermined times after drug administration. Results are reported as mean ± standard deviation (SD). Total body clearance ( Cl t ) and apparent volume of distribution ( V z ) for the i.v. route were 3.61 ± 0.78 and 0.217 ± 0.03 mL/kg, respectively. Terminal half‐life harmonic mean ( t ½λ) was 0.88; 1.17 and 01.73 h for the i.v., i.m and s.c. routes, respectively. Mean peak serum concentration ( C max ) was 115.10 ± 16.96 and 69.28 ± 14.55 μg/mL for the i.m and s.c. routes, respectively. Time to reach C max ( t max ) was 0.54 ± 0.24 and 1.29 ± 00.64 h for the i.m and s.c. routes, respectively. Mean absorption time ( MAT ) was 1.02 ± 0.64 and 2.23 ± 00.73 h for the i.m and s.c. routes, respectively. Bioavailability was 102 ± 27 and 106 ± 14% for the i.m and s.c. routes, respectively. Statistically significant differences were determined in C max , t max , MAT and t ½λ of s.c. administered ceftriaxone when compared with the i.v and i.m. routes. These findings suggest that once or twice s.c. or i.m. daily administered ceftriaxone should be adequate to treat most susceptible infections in dogs.